Testing a new screening tool for colorectal cancer in people with negative FIT results
Part of Cancer, Digestive system clinical trials.
This trial tests a new device called Gixam to see if it can help find colorectal cancer in people who recently had a normal FIT test (a stool test for blood). You may be able to join if you are between 45 and 85 years old and are already scheduled for a routine screening colonoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 85 years old.
- You are scheduled for a routine screening colonoscopy (not because you have symptoms).
- You have not had a colonoscopy in the last 9 years (unless it was incomplete due to poor bowel prep and done within the past year).
- You do not have a personal or family history of colorectal cancer or certain genetic conditions linked to colon cancer.
- You have not taken probiotics in the last 3 months, and you haven't had a dental visit in the past week before the Gixam test.
- You do not have a tongue piercing or a condition that makes it hard to stick out your tongue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
This study collects body samples to help evaluate tests for people with suspected or newly diagnosed colorectal conditions, often around the time of colonoscopy or surgery. Depending on the arm, you may be asked to have a colonoscopy soon or to provide samples before planned surgery.
This trial tests a multilevel support program to help patients who had an abnormal FIT (fecal immunochemical test) result get a follow-up colonoscopy. The goal is to increase colorectal cancer screening completion.
This trial tests a new test (called Gixam) that uses a sample from your mouth to help find pre-cancerous growths or colorectal cancer. It may offer a less invasive way to check for cancer risk when you already need a colonoscopy.
This study is testing a new, non-invasive tongue test called Gixam. The goal is to see if the test can help detect colorectal cancer or pre-cancerous growths in people whose standard stool tests (FIT) came back negative, potentially improving screening accuracy.
This trial compares different ways to screen healthy adults aged 45–74 for colorectal cancer using non-invasive tests. If you join, you will help find the best method to catch cancer early and prevent it.
Hear when a new Colorectal Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.